Hansen · Scientific reports 2024 · Comparative experimental neurophysiology study · n=?

Light-based gamma entrainment with novel invisible spectral flicker stimuli.

Cited 11 times in the scientific literature.

Level 3 - non-randomized controlled study

Prospective comparative human experimental study without randomized trial details specified in abstract

PubMed 39613776 · doi:10.1038/s41598-024-75448-4 · record verified 2026-08-31

What was done

The authors evaluated invisible spectral flicker (ISF)—a novel 40 Hz light-based gamma entrainment modality—against traditional luminance flickering (LF) and chromatic flicker (CF). They measured 40 Hz steady-state visually evoked potentials (SSVEP), subjective comfort ratings, and perceived flicker. They also examined the effects of varying stimulation brightness and presenting ISF from increasingly peripheral visual angles.

What was found

No numerical values or p-values are reported in the abstract. Qualitatively, ISF, LF, and CF all elicited 40 Hz SSVEP responses. ISF scored significantly better than the comparators on measures of subjective comfort and perceived flicker. Reducing stimulation brightness significantly improved comfort without significantly diminishing 40 Hz SSVEP response or perceived flicker (though a non-significant trend toward lower SSVEP was noted). Stimulating from peripheral angles resulted in a slight reduction in 40 Hz SSVEP.

Why it matters

Standard 40 Hz light therapies for Alzheimer's disease cause visual discomfort that hampers clinical adherence; ISF provides a method to elicit gamma entrainment with minimal perceived flicker, potentially allowing more tolerable direct or peripheral administration.

Limits

The abstract provides no sample size (n), participant characteristics (healthy volunteers vs. patients with cognitive impairment), or numerical data (effect sizes, variance, p-values). The study only assessed acute electrophysiological and comfort endpoints rather than long-term adherence, safety, or therapeutic efficacy in Alzheimer's disease.

Cited by